At the Regulatory Education for Industry (REdI) Conference, regulatory educators from the U.S. Food and Drug Administration (FDA) provide information to small drug and device manufacturers. On May 18, 2016, Kristen Miller, PharmD of OMP/CDER, will provide an overview of CTTI. CTTI was co-founded as a public-private partnership between Duke University and the FDA and develops projects culminating in recommendations and tools for transformational changes to clinical trials.

The presentation will review why CTTI was created, its mission and vision, CTTI’s array of projects, recommendations and implementation tools available, and how implementing the proposed changes could help to improve the clinical trial enterprise. CTTI was established as a public-private partnership between Duke and FDA and now comprises over 70 member organizations representing all stakeholders from across the clinical trials enterprise.

If you are attending the conference, we invite you to attend the session:

REdI Spring 2016 Conference

Conference Location: Bloomington, Minnesota

Topic: Increasing the Quality and Efficiency of Clinical Trials: The Clinical Transformation Trials Initiative (CTTI)
Date & Time: Wednesday, May 18, 2016, from 1:00-2:00 PM
Speaker: Kristen Miller, FDA/CDER